X
07Jan

DEAL WATCH: End-of-Year Biosimilar Agreements

Goodwin | | Return|
Following the string of biosimilar agreements announced in early November, a number of additional transactions were announced in early December, bringing 2019 to a roaring close with global biosimilars deals. On December 1, 2019, Luye Pharma Group...
By: Goodwin
Source Url: https://www.jdsupra.com/legalnews/deal-watch-end-of-year-biosimilar-10061/

Related

Financial Daily Dose 12.05.2019 | Top Story: CBS and Viacom Finalize Deal to Reunite Media Empire

CBS and Viacom are back together again. The deal to reunite the former partners, which closed late y...

Read More >

Don’t Fail to Act: Employer Duties in Addressing Co-Worker Manager Sexual Harassment

Don’t Fail to Act: Employer Duties in Addressing Co-Worker Manager Sexual Harassment Over half of...

Read More >

HSR Early Terminations Halted And FTC and DOJ Implement Temporary E-Filing During COVID-19 Telework Directive

In response to COVID-19, the Premerger Notification Office (PNO) at the Federal Trade Commission (FT...

Read More >

Not All Damages Are Created Equal – the Proper Application of the Economic Loss Doctrine

In William Lansing v. Doe, 2019 Ore. App. LEXIS 1564, the Court of Appeals of Oregon considered whet...

Read More >

Scabby The Rat Could Face Extermination Under Labor Board General Counsel’s Recommendation

A recent Advice Memorandum from the National Labor Relations Board’s (NLRB) General Counsel’s offi...

Read More >

Potential Impacts of COVID-19 on Construction Projects in Canada

The COVID-19 pandemic has been a considerable source of discussion and, despite multiple publication...

Read More >